Transscleral albumin diffusion and suprachoroidal albumin concentration in uveal effusion syndrome

Retina

Volumn 32, Issue 1, 2012, Pages 177-182

  Jackson, Timothy L ^a,b   Hussain, Ali ^b   Salisbury, Jon ^a   Sherwood, Roy ^a   Sullivan, Paul M ^c   Marshall, John ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

albumin; diffusion; nanophthalmic; permeability; sclera; uveal effusion syndrome

Indexed keywords

ALBUMIN; COLLAGEN FIBRIL; FLUORESCEIN ISOTHIOCYANATE; LATANOPROST; MUCIN; PROTEIN;

ADULT; ALBUMIN BLOOD LEVEL; ALBUMIN CHROIDAL LEVEL; ANALYTICAL PARAMETERS; ARTICLE; BODY TEMPERATURE; CASE REPORT; CHOROID; COLLAGEN DEGRADATION; CONTROLLED STUDY; DIFFUSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERMETROPIA; MALE; PERMEABILITY; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY; TRANSMISSION ELECTRON MICROSCOPY; TRANSSCLERAL ALBUMIN DIFFUSION; UVEA DISEASE; UVEAL DIFFUSION SYNDROME; UVEAL DISEASE; UVEAL EFFUSION SYNDROME;

ALBUMINS; CASE-CONTROL STUDIES; CHOROID; DIFFUSION; HUMANS; MALE; MIDDLE AGED; PERMEABILITY; SCLERA; SYNDROME; UVEAL DISEASES;

EID: 84855192608     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318218a95a     Document Type: Article

References (18)

1. Elagouz M, Stanescu-Segall D, Jackson TL. Uveal effusion syndrome. Surv Ophthalmol 2010;55:134-145.
2. Gass JDM. Uveal effusion syndrome: A new hypothesis concerning pathogenesis and technique of surgical treatment. Retina 1983;3:159-163. (Pubitemid 14243828)
3. Yue BYJT, Duvall J, Goldberg MF, et al. Nanophthalmic sclera: morphologic and tissue culture studies. Ophthalmology 1986;93:534.
4. Brockhurst RJ. Vortex vein decompression for nanophthalmic uveal effusion. Arch Ophthalmol 1980;98:1987-1990. (Pubitemid 11250650)
5. Gass JDM, Jallow S. Idiopathic serous detachment of the choroid, ciliary body, and retina (uveal effusion syndrome). Ophthalmology 1982;89:1018-1032. (Pubitemid 12001631)
6. Trelstad RL, Silbermann NN, Brockhurst RJ. Nanophthalmic sclera: ultrastructural, histochemical, and biochemical observations. Arch Ophthalmol 1982;100:1935-1938. (Pubitemid 13240994)
7. Ward RC, Gragoudas ES, Pon DM, Albert DM. Abnormal scleral findings in uveal effusion syndrome. Am J Ophthalmol 1988;106:139-146.
8. Jackson TL, Hussain A, Morley AMS, et al. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome. Invest Ophthalmol Vis Sci 2008;49: 5033-5040.
9. Levick JR. Flow through interstitium and other fibrous matrices. Q J Exp Physiol 1987;72:409-437.
10. Boubriak OA, Urban JP, Bron AJ. Differential effects of aging on transport properties of anterior and posterior human sclera. Exp Eye Res 2003;76:701-703.
11. Weinreb RN. Enhancement of scleral macromolecular permeability with prostaglandins. Trans Am Ophthalmol Soc 2001; 99:319-343. (Pubitemid 40525416)
12. Anderson OA, Jackson TL, Singh JK, et al. Human transscleral albumin permeability and the effect of topographical location and donor age. Invest Ophthalmol Vis Sci 2008;49:4041-4045.
13. Kundaiker S, Hussain AA, Marshall J. Component characteristics of the vectorial transport system for taurine in isolated bovine retinal pigment epithelium. J Physiol 1996;492: 505-516. (Pubitemid 26137759)
14. Jackson TL, Antcliff RJ, Hillenkamp J, Marshall J. Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci 2003;44: 2141-2146. (Pubitemid 36520310)
15. Bill A. Movement of albumin and dextran through the sclera. Arch Ophthalmol 1965;74:248-252.
16. Calhoun FP Jr. The management of glaucoma in nano-phthalmos. Trans Am Ophthalmol Soc 1975;73:97-122.
17. Toris CB, Pederson JE, Tsuboi S, et al. Extravascular albumin concentration of the uvea. Invest Ophthalmol Vis Sci 1990;31:43-53. (Pubitemid 20042463)
18. Allansmith MR, Whitney CR, McClellan BH, Newman LP: Immunoglobulins in the human eye: location, type and amount. Arch Ophthalmol 1973;89:36-45.